1 |
Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31:204-9.
DOI
|
2 |
Batra CM, Gupta N, Atwal G, Gupta V. Transient neonatal diabetes due to activating mutation in the ABCC8 gene encoding SUR1. Indian J Pediatr 2009;76:1169-72.
DOI
ScienceOn
|
3 |
McGowan JE. Hypo- and hyperglycemia and other carbohydrate metabolism disorders. In: Thureen PJ, Hay WWJ, editors. Neonatal nutrition and metabolism. 2nd ed. Cambridge: Cambridge University Press, 2006;454-65.
|
4 |
Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. In: Chiarelli F, Dahl-Jorgensen K, Kiess W, editors. Diabetes in childhood and adolescence. Basel: Karger, 2005;10:72-83.
|
5 |
Babenko AP, Polak M, Cave H, Busiah K, Czernichow P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006;355:456-66.
DOI
ScienceOn
|
6 |
Zung A, Glaser B, Nimri R, Zadik Z. Glyburide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 2004;89:5504-7.
DOI
ScienceOn
|
7 |
Tonini G, Bizzarri C, Bonfanti R, Vanelli M, Cerutti F, Faleschini E, et al. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. Diabetologia 2006;49:2210-3.
DOI
ScienceOn
|
8 |
Mohamadi A, Clark LM, Lipkin PH, Mahone EM, Wodka EL, Plotnick LP. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM. Pediatr Diabetes 2010;11:203-7.
|
9 |
Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 2007;92:3979-85.
DOI
ScienceOn
|
10 |
Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007;56:1930-7.
DOI
ScienceOn
|
11 |
Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-49.
DOI
ScienceOn
|
12 |
Ozlu F, Tyker F, Yuksel B. Neonatal diabetes mellitus. Indian Pediatr 2006;43:642-5.
|
13 |
Kim MS, Kim SY, Kim GH, Yoo HW, Lee DW, Lee DY. Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2. J Korean Med Sci 2007;22:616-20.
DOI
ScienceOn
|